Woman Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
• To estimate the pCR rate of AC followed by ixabepilone relative to the pCR rate for AC followed by paclitaxel in women with early stage breast cancer. • To estimate the pCR rate of AC followed by ixabepilone relative to the pCR rate for AC followed by paclitaxel in a biomarker-defined population based on the following pre-defined biomarker sets: − β3 tubulin assessed by immunohistochemistry (IHC), − CAPG assessed by mRNA, − TACC3 assessed by mRNA, − A set of 20 genes assessed by mRNA, − A set of 26 genes assessed by mRNA.
Inclusion criteria
- Breast Cancer